The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Fecal microbiota transplantation for refractory immune-checkpoint-inhibitor colitis.
 
Arielle Elkrief
No Relationships to Disclose
 
Waters Nicholas
No Relationships to Disclose
 
Natalie Smith
No Relationships to Disclose
 
Angel Dai
No Relationships to Disclose
 
John B Slingerland
No Relationships to Disclose
 
Nathaniel Aleynick
No Relationships to Disclose
 
Melissa Amy Lumish
No Relationships to Disclose
 
Paul Giardina
No Relationships to Disclose
 
Jamie E. Chaft
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Flame Biosciences; Genentech/Roche; Guardant Health; Janssen Oncology; Merck; Novartis; Sanofi/Regeneron
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Paul B. Chapman
Stock and Other Ownership Interests - Rgenix
Consulting or Advisory Role - Black Diamond Therapeutics; GigaGen; Merck; Pfizer
Research Funding - Genentech; GigaGen; Merck; NCI (Inst); Pfizer
 
Juliana Eng
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - AstraZeneca; Aveo; Calithera Biosciences; Eisai; EMD Serono; Exelixis; Genentech/Roche; Incyte; Merck; Pfizer
Research Funding - Aveo (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Robin B Mendelsohn
Consulting or Advisory Role - Exact Sciences
Speakers' Bureau - Medscape
 
Marcel R. M. Van Den Brink
Honoraria - BeiGene (I); Ceramedix; Da Volterra; Forty Seven; Frazier Healthcare Partners; GlaxoSmithKline; Lygenesis; Magenta Therapeutics; Merck; Nektar; Notch Therapeutics; Novartis (I); Pluto Immunotherapeutics; Priothera; Rheos Medicines; Seres Therapeutics; Synthekine (I); WindMIL; WindMIL
Consulting or Advisory Role - Seres Therapeutics
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - Dr. van den Brink receives royalties from Wolters Kluwer, and he has intellectual property Licensing with Seres Therapeutics and Juno Therapeutics
Travel, Accommodations, Expenses - Rheos Medicines
Other Relationship - DKMS
(OPTIONAL) Uncompensated Relationships - Notch Therapeutics; Pluto Immunotherapeutics; Seres therapeutics
 
Jinru Shia
Consulting or Advisory Role - PAIGE.AI
 
Susan DeWolf
No Relationships to Disclose
 
Matthew David Hellmann
Employment - AstraZeneca
Stock and Other Ownership Interests - Arcus Biosciences; AstraZeneca; Factorial; Immunai; Shattuck Labs; Shattuck Labs
Consulting or Advisory Role - Achilles Therapeutics; Adagene; Adicet Bio; Arcus Biosciences; AstraZeneca/MedImmune; Blueprint Medicines; Bristol-Myers Squibb; Genentech; Immunai; Instil Bio; Janssen; Lilly; Mana Therapeutics; Merck; Mirati Therapeutics; Natera; PACT Pharma; Regeneron; Sanofi; Shattuck Labs
Research Funding - Bristol-Myers Squibb (Inst)
Patents, Royalties, Other Intellectual Property - A patent has been filed by Memorial Sloan Kettering (PCT/US2015/062208) for the use of tumor mutation burden for prediction of immunotherapy efficacy, and which is licensed to Personal Genome Diagnostics. (Inst)
 
Jonathan U. Peled
Stock and Other Ownership Interests - Postbiotics Inc.; Seres Therapeutics (Inst)
Consulting or Advisory Role - CSL Behring; Da Volterra; MaaT Pharma
Research Funding - Seres Therapeutics
Patents, Royalties, Other Intellectual Property - filed intellectual property applications related to the microbiome; IP licensing fees, Seres Therapeutics
Travel, Accommodations, Expenses - Seres Therapeutics
 
David M. Faleck
Consulting or Advisory Role - Equillium; Kaleido Biosciences; Mallinckrodt; OnQuality Pharmaceuticals